Abstract:Sir,We read with great interest the article published in Brain by Tezenas du Montcel et al. (2014) reporting modifying factors of age-at-onset in 1255 individuals affected with spinocerebellar ataxia (SCA) types 1, 2, 3, 6 and 7, recruited through the European Consortium on Spinocerebellar Ataxias (EUROSCA). We would like to report our findings on genetic modifiers and age-at-onset in 802 Chinese Han patients (429 males, 373 females) with Machado-Joseph disease (MJD/SCA3), on behalf of the Chinese Clinical Research Cooperative Group for Spinocerebellar Ataxias (CCRCG-SCA). Our study was approved by the ethics committee of Xiangya Hospital, Central South University. Blood samples were collected after written informed consent from all subjects. All MJD patients were genotyped for ATXN3 and nine other polyQ-related genes ( ATXN1 , ATXN2 , CACNA1A , ATXN7 , TBP , ATN1 , KCNN3 , RAI1 and HTT ). None of the MJD patients was a ‘homozygote’ (i.e. bearing two expanded alleles).We used a similar statistical strategy as described by the EUROSCA consortium (Tezenas du Montcel et al. , 2014). For some polyQ-related genes ( ATXN1 , TBP , ATN1 and HTT ), the sizes of the shorter and the longer alleles were considered (separately) as continuous variables; given the skewed distribution of allele size in the other genes ( ATXN2 , ATXN3 , ATXN7 , CACNA1A and RAI1 ) these were classified as short, short-medium, medium or long (Table 1). The interaction between both alleles, their mean length and the size difference between alleles at each locus were also considered as dependent variables. View this table:Table 1 Classification of polyQ-related normal alleles according to the number of CAG repeatsThe logarithmically transformed age-at-onset was treated as a dependent variable with homoscedasticity. Linear regression analysis (linear and quadratic effects) was performed to estimate the effect on age-at-onset of the expanded allele at ATXN3. Different models were then …

[Molecular Diagnosis of Huntington's Disease: an Analysis of Two Large Families].

IT15 gene analysis in two pedigrees of Huntington's disease]

Gene analysis of two families with Huntington disease

Clinical Characteristics of Huntington Disease in Two Pedigrees and Analysis of Expanded CAG Trinucleotide Repeat

Clinical and Genetic Profiles in Chinese Patients with Huntington's Disease: A Ten-year Multicenter Study in China.

Loss of CAA Interruption and Intergenerational CAG Instability in Chinese Patients with Huntington’s Disease

[Genetic and Clinical Analysis in a Parkinson's Disease Family Caused by Expansion of SCA2].

Haplotype Analysis Encompassing HTT Gene in Chinese Patients with Huntington's Disease

Ccg Polymorphisms in the Huntingtin Gene Have No Effect on the Pathogenesis of Patients with Huntington'S Disease in Mainland Chinese Families

Clinical Features Of Chinese Patients With Huntington'S Disease Carrying Cag Repeats Beyond 60 Within Htt Gene

SYBR Green I Analysis of the Trinucleotide Repeat Responsible for Huntington’s Disease

Genetic diagnosis of Hailey-Hailey disease in two Chinese families: novel mutations in the ATP2C1 gene.

DNA Analysis of a Pedigree with Myotonic Dystrophy in Songjiang County, Shanghai.

Progress in studies of gene therapy for Huntington's disease

Integrated analysis on transcriptome and behaviors defines HTT repeat-dependent network modules in Huntington's disease

MGB Probe Assay for Rapid Detection of Mtdna11778 Mutation in the Chinese LHON Patients by Real-Time PCR

A modifier of Huntington's disease onset at the MLH1 locus

Development of Research on Huntington Disease in China

Comprehensive Genetic Diagnosis of Patients with Duchenne/Becker Muscular Dystrophy (DMD/BMD) and Pathogenicity Analysis of Splice Site Variants in the DMD Gene

Advances in Gene and Cellular Therapeutic Approaches for Huntington’s Disease

(CAG)n loci as genetic modifiers of age-at-onset in patients with Machado-Joseph disease from mainland China.